You are here
First Oral Drug Increases Activity of the Body’s Deficient Enzyme
First in a New Class of siRNA Therapeutics
Venous Thromboembolism and Other Risks to Be Evaluated in Postmarketing Studies
New Algorithm Surveys Alterations in DNA and Millions of Points in the Human Genome
Researchers Recommend Increased Testing for Men
New Draft Guidance Seeks to Better Target Patient Needs
Dangers After Donor Stem Cell Transplant
It’s All in How the Data Are Analyzed
Two Phase 3 Studies Met Endpoint of Complete Clearance of Lesions
Radiation Exposure Remains a Risk
Quality Metrics Will Provide Feedback to Manufacturers
Drugmaker Aiming for 25–30 New Drugs by 2022
HHS proposal designed to prevent ‘Shkrelis,’ not high drug prices overall
Some studies had linked the device to harmful side effects.
Claims that tramiprosate helps stabilize patients over an 18-month period.
The biomarker can track a number of bodily functions.
Part of an ongoing effort to better oversee use of compounded medications.
An impurity has been found to be carcinogenic.
But diabetes group tamp down expectations.
Some see the loss of an important, unbiased source of information.